OrganiGram Holdings Inc.

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OrganiGram Holdings, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. Its brands include Edison, Big Bag O’ Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.

Cronos Group

HEXO Corp

As the global cannabis sector gains traction, Canadian cannabis stocks remain at the vanguard, providing investors with attractive options in a quickly expanding market. The cannabis sector in Canada has grown dramatically, attracting investors from all walks of life. The country's forward-thinking approach to cannabis legalization, as well as its strong regulatory structure, have created a climate that encourages growth, innovation, and profitability. As a result, with companies at various phases of development and diversification, Canadian cannabis stocks have emerged as an interesting investment opportunity.

Top Canadian Penny Stocks To Buy? 3 To Watch

Aurora Cannabis

Tilray Brands

Marijuana stock investors are on high alert. The reason is many who are invested in cannabis are watching for the next recovery. Much of the sector has faced the same fate of seeing more pullback than upward trading. Now even with more chances to find the best marijuana stocks to buy people want to see better trading. A handful of investors feel that you can still play the market when a volatile pop occurs. Yet the inconsistency makes it tough to predict when that will be. Especially with increasing concerns about new rules and regulatory issues.

3 Marijuana Stocks To Watch Right Now In June

British American Tobacco

Canopy Growth

Altria

SNDL Inc.

Village Farms International

Canadian LPs are now down in 2023 and down a lot since 2018. The two most popular LPs, Canopy Growth and Tilray, have imploded. Some Canadian LPs are trading very cheaply and could do better.

Don't Avoid All Canadian Cannabis Producers

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that it has reached agreement with Phylos Bioscience Inc. (“Phylos”), a U.S. cannabis genetics company and provider of production ready seeds, based in Portland, Oregon, to initiate a wide-ranging technical and commercial relationship in Canada. This innovation relationship is expected to further support Organigram's industry lead.

Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce today that it has entered into a supply agreement (“the Agreement”) for dried flower with the medical division of German cannabis company Sanity Group, a health and life sciences company based in Berlin, Germany, dedicated to the medical applications of cannabinoids. Through exports from its flagship state-of-the-art cultiv.

Organigram to Enter German Market Supplying Sanity Group

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that its wholly-owned subsidiary, The Edibles and Infusions Corporation (“EIC”) has met certain of the remaining earnout milestones that formed part of the terms of its acquisition in April, 2021. Organigram acquired EIC in April 2021 for consideration of $22 million plus up to an additional $13 million in share consideration base.

Organigram Announces Achievement of Earnout by The Edibles and Infusions Corporation

Canadian Pot Stocks To Watch In May The post Canadian Cannabis Stocks Under $2 To Watch Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Cannabis Stocks Under $2 To Watch Now

I have followed Organigram closely since it went public in 2014. I find the valuation currently to be extremely cheap, and OGI is the largest position in my model portfolio.

Organigram Is The Best Cannabis Stock

Organigram has better gross margins than most of its competition. The company has gradually improved margins over the last several quarters and even managed to post a positive return on capital Q4 2022.

Organigram Is Almost There

Top 2 Marijuana Stocks For Investing In Legal Cannabis The post 2 Marijuana Stocks To Buy In Todays Stock Market? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks To Buy In Todays Stock Market?

The Best 3 Marijuana Stocks Right Now In The Market The post 3 Stocks To Buy In The Stock Market On 420 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Stocks To Buy In The Stock Market On 420

WM Technology

Scotts Miracle-Gro

Here are seven steps to investing in the high-flying cannabis industry.

7 Steps to Investing in Marijuana Stocks

Organigram's Q2 sales and earnings performance fell short of the market's expectations. While the company did manage to grow its adjusted gross margin and EBITDA, pricing compression is hurting revenue.

Why Organigram Holdings Stock Is Plummeting Today

Organigram's latest quarterly results demonstrated the strength of its international sales growth while its performance in the recreational (REC) segment was weak, analysts at Stifel GMP highlighted. In a note to clients, the analysts observed that the Moncton, New Brunswick-based cannabis producer's fiscal second quarter 2023 results were mixed, missing on revenues but with significantly higher than expected gross margins.

Organigram's strong international sales growth during 2Q cause for optimism, Stifel analysts say

Organigram Holdings Inc. (NASDAQ:OGI ) Q2 2023 Results Conference Call April 12, 2023 8:00 AM ET Company Participants Max Schwartz - Director, IR Beena Goldenberg - CEO Derrick West - CFO Conference Call Participants Andrew Partheniou - Stifel GMP Tamy Chen - BMO Capital Markets Frederico Gomes - ATB Capital Markets Aaron Grey - Alliance Global Partners Michael Freeman - Raymond James Operator Good morning. My name is Rob, and I will be your conference operator today.

Organigram Holdings Inc. (OGI) Q2 2023 Earnings Call Transcript

OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) has reported second-quarter revenue and earnings that fell short of analyst estimates, sending its shares lower in Wednesday pre-market trade.  However, the cannabis producer noted that its gross profit margins improved as it increased efficiencies and sold more product, including higher international sales.

Organigram shares fall as 2Q results fail to fire up investors

OrganiGram (OGI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.02 per share a year ago.

OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2023 (“Q2 Fiscal 2023”). All financial information in this press release is expressed in thousands of Canadian dollars ("$"), except for references to $ millions. “We are pleased with our results in a quarter with typical seasonality.

Organigram Reports Second Quarter Fiscal 2023 Results

A thriving black market and a glut of legal operators have weighed on profit margins in the Canadian cannabis space. This key pressure is likely to drive a wave of consolidation across the industry in the years to come.

Which Canadian Cannabis Company Will Be the Next Takeover Target?

With two Canadian cannabis earnings results announcements set to kick off this week, Organigram's shares are solidly in the green today. The company's stock got an additional boost from a renewed call to expedite the ongoing scheduling review for cannabis in the United States.

Why Organigram Holdings Stock Is Perking Up Today

Neptune Wellness Solutions Inc.

Top Marijuana Stocks For Cannabis Investing The post 2 Top Marijuana Stocks For Cannabis Investing 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Top Marijuana Stocks For Cannabis Investing 2023

After a tough 2022 for cannabis stocks, investors will be looking to companies such as Tilray Brands and Organigram Holdings as they report their latest quarterly results to see how the industry is faring in the first three months of 2023. New York-based Tilray is set to report its 3Q fiscal 2023 results after the market close on April 10, but analysts aren't too optimistic about the company's recent performance.

Tilray and Organigram to report earnings: can either cannabis company deliver an upside surprise?

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2023 ended February 28, 2023, on Tuesday, April 11, 2023, after market close.

Organigram to Report Second Quarter Fiscal 2023 Results on April 11, 2023

Top Marijuana Stocks To Watch The First Week Of April The post Don't Be An April Fool 2 Marijuana Stocks To Buy? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Don't Be An April Fool 2 Marijuana Stocks To Buy?

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it has entered into a product purchase agreement (“Purchase Agreement”) with Green Tank Technologies Corp. (“Greentank”) a leading vaporization technology company and a subscription agreement (“Subscription Agreement”) with Greentank's parent company, Weekend Holdings Corp (“Holdings”).

News for OrganiGram Holdings Inc. Stock (OGI)